go-v.orgdoi

A Study to Evaluate the Effect of Repeat Oral Doses of Darapladib on Cardiac Conduction as Compared to Placebo and a Single Oral Dose of Moxifloxacin

GlaxoSmithKline · Vivli · 2018

  • DOI 10.25934/00000072
  • Publisher Vivli
  • Type dataset
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Vivli · Vivli · dataset · 2018

Abstract

This is a study to assess the effects of darapladib on the cardiac conduction of the heart as compared to placebo and moxifloxacin. This a four period crossover design with each period lasting about 10 days. There will be a 7 to 10 day wash out in between each period.

Open the resolved locator · 10.25934/00000072

Metadata licence: OpenAlex metadata (CC0)